Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: Improvement in psychiatric measures

Journal of Clinical Psychiatry

Volumn 64, Issue 12, 2003, Pages 1449-1454

  Hedges, Dawson W ^a   Reimherr, Frederick W ^b   Hoopes, Scott P ^c   Rosenthal, Norman R ^d   Kamin, Marc ^d   Karim, Rezaul ^d   Capece, Julie A ^d  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c Mountain West Clinical Trials   (United States)

^d Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TOPIRAMATE; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE;

ANXIETY; APTITUDE TEST; ARTICLE; BINGE EATING DISORDER; BODY IMAGE; BODY WEIGHT; BULIMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; FEEDING BEHAVIOR; HAMILTON SCALE; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF ESTEEM; TITRIMETRY; TREATMENT OUTCOME; ADULT; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; MALE; MULTICENTER STUDY; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; SELF CONCEPT;

ADULT; ANTICONVULSANTS; BODY IMAGE; BULIMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEEDING BEHAVIOR; FEMALE; FRUCTOSE; HUMANS; MALE; PERSONALITY INVENTORY; SELF CONCEPT; TREATMENT OUTCOME;

EID: 1342328636     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n1208     Document Type: Article

References (34)

1. Swartz J. Bulimia: the obsession to be thin. Can Med Assoc J 1984;130:923-924
2. Diehl NS, Johnson CE, Rogers RL, et al. Social physique anxiety and disordered eating: what's the connection? Addict Behav 1998;23:1-6
3. Fernandez F, Probst M, Meermann R, et al. Body size estimation and body dissatisfaction in eating disorder patients and normal controls. Int J Eat Disord 1994;16:307-310
4. Abraham SF, Beumont PJV. How patients describe bulimia or binge eating. Psychol Med 1982;12:625-635
5. Casper RC. Depression and eating disorders. Depress Anxiety 1998;8:96-104
6. Heatherton TF, Baumeister RF. Binge eating as escape from self-awareness. Psychol Bull 1991;110:86-108
7. Zhu AJ, Walsh BT. Pharmacologic treatment of eating disorders. Can J Psychiatry 2002;47:227-234
8. Wilfley DE, Cohen LR. Psychological treatment of bulimia nervosa and binge eating disorder. Psychopharmacol Bull 1997;33:437-454
9. Wilfley DE, Agras WS, Telch CF, et al. Group cognitive-behavioral therapy and group interpersonal psychotherapy for the nonpurging bulimic individual: a controlled comparison. J Consult Clin Psychol 1993;61:296-305
10. Romano SJ, Halmi KA, Sarkar NP, et al. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry 2002;159:96-102
11. Goldstein DJ, Wilson MG, Thompson VL, et al. for the Fluoxetine Bulimia Nervosa Research Group. Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995;166:660-666
12. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992;49:139-147
13. Agras WS, Rossiter EM, Arnow B, et al. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. Am J Psychiatry 1992;149:82-87
14. Hudson JI, McElroy SL, Raymond NC, et al. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry 1998;155:1756-1762
15. Fahy TA, Eisler I, Russell GF. A placebo-controlled trial of d-fenfluramine in bulimia nervosa. Br J Psychiatry 1993;162:597-603
16. Mitchell JE, Pyle RL, Eckert ED, et al. A comparison study of anti-depressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 1990;47:149-157
17. Mitchell JE, Groat R. A placebo-controlled, double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 1984;4:186-193
18. Shapira NA, Goldsmith TD, McElroy SL. Treatment of binge-eating disorder with topiramate: a clinical case series. J Clin Psychiatry 2000;61:368-372
19. McElroy SL, Arnold LM, Shapira NA, et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 2003;160:255-261
20. Knable MB. Topiramate for bulimia nervosa in epilepsy [letter]. Am J Psychiatry 2001;158:322-323
21. Felstrom A, Blackshaw S. Topiramate for bulimia nervosa with bipolar II disorder [letter]. Am J Psychiatry 2002;159:1246-1247
22. Barbee JG. Topiramate in the treatment of severe bulimia nervosa with comorbid mood disorders: a case series. Int J Eat Disord 2003;33: 468-472
23. Hoopes S, Reimherr F, Hedges D, et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binse and purge measures. J Clin Psychiatry 2003;64:1335-1341
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
25. Gamer DM, Olmsted MP, Polivy J. Development and validation of multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int J Eat Disord 1983;2:15-34
26. Garner DM, Olmsted MP, Bohr Y, et al. The Eating Attitudes Test: psychometric features and clinical correlates. Psychol Med 1982;12:871-878
27. Clinical global improvement. In: Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
28. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
29. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55
30. Appolinario JC, Coutinho W, Fontenelle L. Topiramate for binge-eating disorder [letter]. Am J Psychiatry 2001;158:967-968
31. Garner DM, Olmsted MP, Polivy J, et al. Comparison between weight-preoccupied women and anorexia nervosa. Psychosom Med 1984;46:255-266
32. Shank RP, Gardocki JF, Streeter AJ, et al. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000;41(suppl 1):S3-S9
33. Stanley BG, Ha LH, Spears LC, et al. Lateral hypothalamic injections of glutamate, kainic acid, D,L-a-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats. Brain Res 1993;613:88-95
34. Stanley BG, Willett VL III, Donias HW, et al. The lateral hypothalamus: a primary site mediating excitatory amino acid-elicited eating. Brain Res 1993;630:41-49